Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Zomedica's operating income for the twelve months ending Jun 30, 2026 was -$20.75M. For fiscal 2025 it was -$84.35M. The highest annual figure on record is -$5.73M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$84.35M | – |
| FY2024 | Dec 31, 2024 | -$51.05M | – |
| FY2023 | Dec 31, 2023 | -$43.28M | – |
| FY2022 | Dec 31, 2022 | -$21.92M | – |
| FY2021 | Dec 31, 2021 | -$21.37M | – |
| FY2020 | Dec 31, 2020 | -$16.76M | – |
| FY2019 | Dec 31, 2019 | -$19.78M | – |
| FY2018 | Dec 31, 2018 | -$16.58M | – |
| FY2017 | Dec 31, 2017 | -$8.08M | – |
| FY2016 | Dec 31, 2016 | -$5.73M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.08M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.16M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.61M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$64.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$25.07M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.39M | – |
| Q4 FY2023 | Dec 31, 2023 | -$23.07M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.51M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.59M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.31M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.77M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.33M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.13M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.00M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.30M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.33M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.86M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.84M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.39M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.69M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.85M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.17M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.56M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.09M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.59M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.85M | – |
See a number that looks wrong?